ClinicalTrials.Veeva

Menu

Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major Surgery

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Perioperative Myocardial Injury

Study type

Observational

Funder types

Other

Identifiers

NCT02687776
EKNZ 2015-275

Details and patient eligibility

About

Observational cohort study examining the perioperative course of copeptin in patients undergoing elevated-risk surgery.

Enrollment

517 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults >18 years
  • Type of surgery for patients 1 to 30: abdominal aortic aneurysm repair, suprainguinal and infrainguinal vascular surgery, carotid surgery
  • Type of surgery for patients 31 to 500: surgeries with elevated risks in general (as specified by 2014 ESC/ESA Guidelines on non-cardiac surgery:

cardiovascular assessment and management [Kristensen])

Exclusion criteria

  • acute coronary Syndrome (ACS) at presentation (clinical assessment or documentation)
  • Congestive heart failure at presentation (clinical assessment or documentation)
  • Documented severe aortic stenosis (valve area <1cm2)
  • Kidney dysfunction (clearance <50ml/min)
  • Reduced left ventricular ejection fraction (LVEF) (<40%); if no LVEF is available, it will be assumed to be >40%
  • Cancelled surgery
  • Unwilling or unable to provide consent
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant

Trial contacts and locations

2

Loading...

Central trial contact

Eckhard Mauermann, MD; Giovanna Lurati Buse, MD, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems